""

Renal cell carcinoma

Recruiting after consultation
Open recruiting

Neoadjuvant Therapy

There are currently no studies available

Adjuvant Therapy

There are currently no studies available

Metastatic Disease: First-Line-Therapy

Title: A Phase 2, Randomized, Open-Label Study of Nivolumab Combined with Ipilimumab Versus Sunitinib Monotherapy in Subjects with Previously Untreated and Advanced (unresectable or metastatic) non-clear Cell Renal Cell Carcinoma
Phase: II
Contact: Margit Peters-Hornig / Kontaktperson
Email-Address: Margit.Peters-Hornig@med.uni-heidelberg.de
Clinical Investigator: Prof. Dr. Carsten Grüllich
Registration: Keine Registernummer angegeben.
EudraCT-Number: (siehe EU klinisches Studienregister) 2016-000706-12
Title: A phase II single arm clinical trial of a Tailored ImmunoTherapy Approach with Nivolumab in subjects with metastatic or advanced Transitional Cell Carcinoma
Phase: II
Contact: Ulrike Lauterbach / Study Nurse
Email-Address: Ulrike.Lauterbach@med.uni-heidelberg.de
Clinical Investigator: Prof. Dr. Carsten Grüllich
Registration: Die Studie ist bei den U.S. National Institutes of Health(ClinicalTrials.gov) registriert. Siehe NCT02917772
EudraCT-Number: (siehe EU klinisches Studienregister) 2016-004857-33

Metastatic Disease: Follow-Up Care

There are currently no studies available

Surgical Study

Title: Hand-Assisted Laparoscopic Donor Nephrectomy PERiumbilical Versus Pfannenstiel Incision and Return to Normal Physical ACTivity
Phase: N/A
Contact: Klinisches Studienzentrum der Chirurgie (KSC) / Kontaktperson
Email-Address: KSC@med.uni-heidelberg.de
Clinical Investigator: PD Dr. Yakub Kulu
Registration: Die Studie ist bei den U.S. National Institutes of Health(ClinicalTrials.gov) registriert. Siehe NCT03317184
EudraCT-Number: Keine Angabe. Nicht-interventionelle Studien oder Studien, die nicht unter das Arzneimittelgesetz fallen, besitzen keine EudraCT-Nummer.

Radiotherapy Study

There are currently no studies available

Other study

There are currently no studies available